Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

OBJECTIVES: The Salford Lung Study in Chronic Obstructive Pulmonary Disease (SLS COPD) is a 12-month, open-label randomized clinical trial comparing clinical effectiveness and safety of initiating once-daily fluticasone furoate/vilanterol (FF/VI) 92/22 mcg with continuing usual care (UC) in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejo-Aparicio, Laura Amanda, Peces-Barba, Germán, Gil, Alicia, Huerta Hernandez, Alicia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132231/
https://www.ncbi.nlm.nih.gov/pubmed/30233222
http://dx.doi.org/10.2147/CEOR.S169154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132231/
https://www.ncbi.nlm.nih.gov/pubmed/30233222
http://dx.doi.org/10.2147/CEOR.S169154

Ejemplares similares